ğ€ğ«ğž 𝐲𝐨𝐮 𝐬𝐭𝐫𝐮𝐠𝐠𝐥𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 ğœğ¨ğ¦ğ©ğ¥ğžğ± ğ«ğžğ ğ®ğ¥ğšğ­ğ¢ğ¨ğ§ğ¬ 𝐬𝐞𝐭 𝐛𝐲 𝐭𝐡𝐞 𝐅𝐃𝐀 𝐚𝐧𝐝 𝐄𝐌𝐀?

ADRES Webinar on Pre-Approval Inspection Readiness

𝐓𝐡𝐢𝐬 ğ°ğžğ›ğ¢ğ§ğšğ« 𝐟𝐨𝐜𝐮𝐬 𝐨𝐧 ğ¢ğ§ğ¬ğ©ğžğœğ­ğ¢ğ¨ğ§ ğ«ğžğšğğ¢ğ§ğžğ¬ğ¬, providing comprehensive insights into the necessary activities and best practices to face regulatory inspections confidently.

This webinar caters explicitly to companies involved in the clinical development of Pharmaceuticals, biologics, and combination products.

We promise to demystify the process and equip you with actionable strategies to transform uncertainty into confidence.

Whether it’s understanding the implications of a Voluntary Action Indicated (VAI) status from a key subcontractor or simply refining your readiness checklist, we’ve got you covered.

If you have any questions or need further assistance, please feel free to reach out to us at https://adres.bio/contact-us.

Join our YouTube channel, where you can find our original videos, with relevant information.


Go back to the Blog
Skip to content